An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease
Clinical trial NCT00790933 · COMPLETED
Trial details
- NCT number
- NCT00790933
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-22
- Primary completion
- 2017-10-31
- Enrollment
- 2243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.